all report title image

ACUTE KIDNEY INJURY TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Acute Kidney Injury Treatment Market, By Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, and Postrenal Acute Kidney Injury), By Treatment (Therapy and Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 03 Apr, 2026
  • Code: CMI4691
  • Page number: 156
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Acute Kidney Injury Treatment Market, By Type
      • Global Acute Kidney Injury Treatment Market, By Treatment
      • Global Acute Kidney Injury Treatment Market, By Distribution Channel
      • Global Acute Kidney Injury Treatment Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Acute Kidney Injury Treatment Market, By Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Prerenal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intrinsic Renal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Postrenal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Acute Kidney Injury Treatment Market, By Treatment, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Acute Kidney Injury Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Acute Kidney Injury Treatment Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • Angion Biomedica Corp.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AM-Pharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Quark Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Baxter International, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fresenius Medical Care AG & Co. KGaA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
      • Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Asahi Kasei Medical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LG Chem
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kringle Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Gilead Sciences
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Acute Kidney Injury Treatment Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.